TSCAN THERAPEUTICS, INC. (TCRX) Operating margin 2020–2025
TSCAN THERAPEUTICS, INC. (TCRX) operating margin by fiscal year — reported operating income divided by reported revenue.
-1315.4%FY2025 · since FY2020: -2417.8% → -1315.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1315.4% | +3472.3 pp |
| FY2024 | -4787.7% | -4343.7 pp |
| FY2023 | -444.0% | +48.3 pp |
| FY2022 | -492.3% | -12.7 pp |
| FY2021 | -479.6% | +1938.1 pp |
| FY2020 | -2417.8% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice